ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial

CONCLUSIONS: Among phenotypically similar patients with angina with nonobstructive coronary arteries, only those with an impaired CFR derive benefit from anti-ischemic therapy. These findings support measurement of CFR to diagnose and guide management of this otherwise heterogeneous patient group.PMID:37905403 | DOI:10.1161/CIRCULATIONAHA.123.066680

Source: Circulation - October 31, 2023 Category: Cardiology Authors: Aish Sinha Haseeb Rahman Abdel Douiri Ozan M Demir Kalpa De Silva Brian Clapp Ian Webb Ankur Gulati Pedro Pinho Utkarsh Dutta Howard Ellis Ajay M Shah Amedeo Chiribiri Michael Marber Andrew J Webb Divaka Perera Source Type: research